BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 19655751)

  • 21. Function-related regulation of the stability of MHC proteins.
    Simon A; Dosztányi Zs; Rajnavölgyi E; Simon I
    Biophys J; 2000 Nov; 79(5):2305-13. PubMed ID: 11053110
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Degenerate recognition of T cell epitopes: impact of T cell receptor reserve and stability of peptide:MHC complexes.
    Ford ML; Evavold BD
    Mol Immunol; 2004 Feb; 40(14-15):1019-25. PubMed ID: 15036905
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural prediction of peptides bound to MHC class I.
    Fagerberg T; Cerottini JC; Michielin O
    J Mol Biol; 2006 Feb; 356(2):521-46. PubMed ID: 16368108
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Noble metals strip peptides from class II MHC proteins.
    De Wall SL; Painter C; Stone JD; Bandaranayake R; Wiley DC; Mitchison TJ; Stern LJ; DeDecker BS
    Nat Chem Biol; 2006 Apr; 2(4):197-201. PubMed ID: 16505807
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The outermost N-terminal region of tapasin facilitates folding of major histocompatibility complex class I.
    Roder G; Geironson L; Darabi A; Harndahl M; Schafer-Nielsen C; Skjødt K; Buus S; Paulsson K
    Eur J Immunol; 2009 Oct; 39(10):2682-94. PubMed ID: 19728311
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peptide-binding motif prediction by using phage display library for SasaUBA*0301, a resistance haplotype of MHC class I molecule from Atlantic Salmon (Salmo salar).
    Zhao H; Hermsen T; Stet RJ; Skjødt K; Savelkoul HF
    Mol Immunol; 2008 Mar; 45(6):1658-64. PubMed ID: 18206244
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Directed evolution of soluble single-chain human class II MHC molecules.
    Esteban O; Zhao H
    J Mol Biol; 2004 Jun; 340(1):81-95. PubMed ID: 15184024
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A flexible MHC class I multimer loading system for large-scale detection of antigen-specific T cells.
    Luimstra JJ; Garstka MA; Roex MCJ; Redeker A; Janssen GMC; van Veelen PA; Arens R; Falkenburg JHF; Neefjes J; Ovaa H
    J Exp Med; 2018 May; 215(5):1493-1504. PubMed ID: 29666167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure of a gammadelta T cell receptor in complex with the nonclassical MHC T22.
    Adams EJ; Chien YH; Garcia KC
    Science; 2005 Apr; 308(5719):227-31. PubMed ID: 15821084
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ab initio prediction of peptide-MHC binding geometry for diverse class I MHC allotypes.
    Bordner AJ; Abagyan R
    Proteins; 2006 May; 63(3):512-26. PubMed ID: 16470819
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular dynamics and structure-based drug design for predicting non-natural nonapeptide binding to a class I MHC protein.
    Scapozza L; Rognan D; Folkers G; Daser A
    Acta Crystallogr D Biol Crystallogr; 1995 Jul; 51(Pt 4):541-9. PubMed ID: 15299842
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modeling the structure of bound peptide ligands to major histocompatibility complex.
    Tong JC; Tan TW; Ranganathan S
    Protein Sci; 2004 Sep; 13(9):2523-32. PubMed ID: 15322290
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A T cell receptor flattens a bulged antigenic peptide presented by a major histocompatibility complex class I molecule.
    Tynan FE; Reid HH; Kjer-Nielsen L; Miles JJ; Wilce MC; Kostenko L; Borg NA; Williamson NA; Beddoe T; Purcell AW; Burrows SR; McCluskey J; Rossjohn J
    Nat Immunol; 2007 Mar; 8(3):268-76. PubMed ID: 17259989
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The importance of extended conformations and, in particular, the PII conformation for the molecular recognition of peptides.
    Siligardi G; Drake AF
    Biopolymers; 1995; 37(4):281-92. PubMed ID: 7540055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is the activity of partially agonistic MHC:peptide ligands dependent on the quality of immunological help?
    Uhlin M; Masucci M; Levitsky V
    Scand J Immunol; 2006 Dec; 64(6):581-7. PubMed ID: 17083613
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aggregate formation by ERp57-deficient MHC class I peptide-loading complexes.
    Stepensky D; Bangia N; Cresswell P
    Traffic; 2007 Nov; 8(11):1530-42. PubMed ID: 17822402
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ligand Design for Specific MHC Class I Molecules on the Cell Surface.
    Sun X; Tokunaga R; Nagai Y; Miyahara R; Kishimura A; Kawakami S; Katayama Y; Mori T
    Biochemistry; 2020 Dec; 59(49):4646-4653. PubMed ID: 33252220
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heat shock protein-90 inhibitors increase MHC class I-related chain A and B ligand expression on multiple myeloma cells and their ability to trigger NK cell degranulation.
    Fionda C; Soriani A; Malgarini G; Iannitto ML; Santoni A; Cippitelli M
    J Immunol; 2009 Oct; 183(7):4385-94. PubMed ID: 19748980
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oriented coupling of major histocompatibility complex (MHC) to sensor surfaces using light assisted immobilisation technology.
    Snabe T; Røder GA; Neves-Petersen MT; Buus S; Petersen SB
    Biosens Bioelectron; 2006 Feb; 21(8):1553-9. PubMed ID: 16139496
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preferential binding of unusually long peptides to MHC class I and its influence on the selection of target peptides for T cell recognition.
    Burrows JM; Bell MJ; Brennan R; Miles JJ; Khanna R; Burrows SR
    Mol Immunol; 2008 Mar; 45(6):1818-24. PubMed ID: 17981331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.